S&P 500   4,037.24 (-0.85%)
DOW   34,209.33 (-0.64%)
QQQ   289.67 (-0.98%)
AAPL   148.42 (+0.41%)
MSFT   251.91 (-1.22%)
META   123.09 (-0.32%)
GOOGL   100.52 (+0.08%)
AMZN   92.69 (-1.53%)
TSLA   184.75 (-5.19%)
NVDA   167.61 (-0.68%)
NIO   12.76 (-2.82%)
BABA   89.99 (-0.08%)
AMD   73.94 (-1.39%)
T   18.91 (-0.58%)
MU   54.46 (-0.40%)
CGC   4.64 (+8.16%)
F   13.51 (-2.53%)
GE   85.32 (-1.80%)
DIS   97.85 (-1.59%)
AMC   8.11 (-0.73%)
PYPL   73.90 (-1.02%)
PFE   50.63 (-0.55%)
NFLX   318.41 (-0.62%)
S&P 500   4,037.24 (-0.85%)
DOW   34,209.33 (-0.64%)
QQQ   289.67 (-0.98%)
AAPL   148.42 (+0.41%)
MSFT   251.91 (-1.22%)
META   123.09 (-0.32%)
GOOGL   100.52 (+0.08%)
AMZN   92.69 (-1.53%)
TSLA   184.75 (-5.19%)
NVDA   167.61 (-0.68%)
NIO   12.76 (-2.82%)
BABA   89.99 (-0.08%)
AMD   73.94 (-1.39%)
T   18.91 (-0.58%)
MU   54.46 (-0.40%)
CGC   4.64 (+8.16%)
F   13.51 (-2.53%)
GE   85.32 (-1.80%)
DIS   97.85 (-1.59%)
AMC   8.11 (-0.73%)
PYPL   73.90 (-1.02%)
PFE   50.63 (-0.55%)
NFLX   318.41 (-0.62%)
S&P 500   4,037.24 (-0.85%)
DOW   34,209.33 (-0.64%)
QQQ   289.67 (-0.98%)
AAPL   148.42 (+0.41%)
MSFT   251.91 (-1.22%)
META   123.09 (-0.32%)
GOOGL   100.52 (+0.08%)
AMZN   92.69 (-1.53%)
TSLA   184.75 (-5.19%)
NVDA   167.61 (-0.68%)
NIO   12.76 (-2.82%)
BABA   89.99 (-0.08%)
AMD   73.94 (-1.39%)
T   18.91 (-0.58%)
MU   54.46 (-0.40%)
CGC   4.64 (+8.16%)
F   13.51 (-2.53%)
GE   85.32 (-1.80%)
DIS   97.85 (-1.59%)
AMC   8.11 (-0.73%)
PYPL   73.90 (-1.02%)
PFE   50.63 (-0.55%)
NFLX   318.41 (-0.62%)
S&P 500   4,037.24 (-0.85%)
DOW   34,209.33 (-0.64%)
QQQ   289.67 (-0.98%)
AAPL   148.42 (+0.41%)
MSFT   251.91 (-1.22%)
META   123.09 (-0.32%)
GOOGL   100.52 (+0.08%)
AMZN   92.69 (-1.53%)
TSLA   184.75 (-5.19%)
NVDA   167.61 (-0.68%)
NIO   12.76 (-2.82%)
BABA   89.99 (-0.08%)
AMD   73.94 (-1.39%)
T   18.91 (-0.58%)
MU   54.46 (-0.40%)
CGC   4.64 (+8.16%)
F   13.51 (-2.53%)
GE   85.32 (-1.80%)
DIS   97.85 (-1.59%)
AMC   8.11 (-0.73%)
PYPL   73.90 (-1.02%)
PFE   50.63 (-0.55%)
NFLX   318.41 (-0.62%)
NASDAQ:NH

NantHealth - NH Stock Forecast, Price & News

$0.25
0.00 (0.00%)
(As of 12/1/2022 11:34 AM ET)
Add
Compare
Today's Range
$0.25
▼
$0.25
50-Day Range
$0.24
▼
$0.39
52-Week Range
$0.17
▼
$1.15
Volume
100 shs
Average Volume
90,378 shs
Market Capitalization
$28.89 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

NantHealth MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Bearish
0.68% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.69
Upright™ Environmental Score
News Sentiment
-0.50mentions of NantHealth in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.34 out of 5 stars

Medical Sector

986th out of 1,033 stocks

Data Processing & Preparation Industry

71st out of 72 stocks

See Top Rated MarketRank™ Stocks Here
NH stock logo

About NantHealth (NASDAQ:NH) Stock

NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform's comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. The company also provides NaviNet, a suite of SaaS-based solution enabling payers and providers to streamline communication and consolidate information; NaviNet Open, a payer-provider collaboration platform for communication between health plans and providers; NaviNet AllPayer that provides eligibility, benefit, and claim status information to provider offices for commercial and government plans and CMS for Medicare beneficiaries through the NaviNet portal; and OpenNMS is an open-source network monitoring solution for enterprise-grade networks. In addition, it offers Quadris, a data solution that includes multi-data analysis, reporting, and professional services. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was incorporated in 2010 and is headquartered in Morrisville, North Carolina. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.

Receive NH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NantHealth and its competitors with MarketBeat's FREE daily newsletter.

NH Stock News Headlines

December 1, 2022 | americanbankingnews.com
NantHealth (NASDAQ:NH) Earns Hold Rating from Analysts at StockNews.com
November 9, 2022 | finance.yahoo.com
NantHealth Third Quarter 2022 Earnings: US$0.12 loss per share (vs US$0.094 loss in 3Q 2021)
November 4, 2022 | finance.yahoo.com
NantHealth Reports 2022 Third Quarter Financial Results
November 1, 2022 | finance.yahoo.com
NantHealth to Report 2022 Third-Quarter Financial Results and Host Conference Call on Thursday, November 3
October 16, 2022 | fool.com
NantHealth, Inc. (NASDAQ: NH)
October 11, 2022 | finance.yahoo.com
WellStack Expands Executive Team with Chief Revenue Officer Christopher Rogowski - Yahoo Finance
October 5, 2022 | benzinga.com
11 Health Care Stocks Moving In Wednesday's Pre-Market Session - Applied DNA Sciences (NASDAQ:APDN), Aven - Benzinga
September 27, 2022 | globenewswire.com
Global Respiratory Care Devices Market expanding at a high-value CAGR of 8.3% by the end of 2032 - GlobeNewswire
September 9, 2022 | uk.investing.com
Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday By Benzinga - Investing.com UK
September 5, 2022 | bizjournals.com
Billionaire's Morrisville firm tries to forestall stock delisting from the Nasdaq
August 24, 2022 | businesswire.com
NantHealth's Eviti Platform Once More Earns Full URAC Accreditation Through 2025 - Business Wire
August 24, 2022 | finance.yahoo.com
NantHealth’s Eviti Platform Once More Earns Full URAC Accreditation Through 2025
August 12, 2022 | finance.yahoo.com
Sarah Chavarria Named President of Delta Dental of California and Affiliates - Yahoo Finance
August 5, 2022 | fool.com
NantHealth, Inc. (NH) Q2 2022 Earnings Call Transcript - The Motley Fool
August 5, 2022 | finance.yahoo.com
NantHealth, Inc. (NH) Q2 2022 Earnings Call Transcript
August 4, 2022 | businesswire.com
NantHealth Reports 2022 Second Quarter Financial Results - Business Wire
August 4, 2022 | finance.yahoo.com
NantHealth Reports 2022 Second Quarter Financial Results
August 1, 2022 | finance.yahoo.com
NantHealth to Report 2022 Second-Quarter Financial Results and Host Conference Call on Thursday, August 4 - Yahoo Finance
August 1, 2022 | businesswire.com
NantHealth to Report 2022 Second-Quarter Financial Results and Host Conference Call on Thursday, August 4 - Business Wire
August 1, 2022 | finance.yahoo.com
NantHealth to Report 2022 Second-Quarter Financial Results and Host Conference Call on Thursday, August 4
July 12, 2022 | streetinsider.com
Xealth Expands Leadership Team with Appointments of Joe Sedlak, RN, and Laurance Stuntz - StreetInsider.com
July 8, 2022 | finance.yahoo.com
NantHealth (NASDAQ:NH) investors are sitting on a loss of 90% if they invested five years ago
June 8, 2022 | finance.yahoo.com
The OpenNMS Group Launches Horizon 30, the Latest Major Release of its Open Source Network Monitoring Solution, Featuring Enhanced Capabilities Designed for the Enterprise
May 17, 2022 | finance.yahoo.com
NantHealth NaviNet Open Wins "Healthcare Insurance Innovation Award" in 2022 MedTech Breakthrough Awards Program - Yahoo Finance
May 6, 2022 | finance.yahoo.com
NantHealth, Inc. (NH) Q1 2022 Earnings Call Transcript
See More Headlines
Receive NH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NantHealth and its competitors with MarketBeat's FREE daily newsletter.

NH Company Calendar

Last Earnings
11/03/2022
Today
12/05/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/23/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Data processing & preparation
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:NH
Previous Symbol
NYSE:NH
CUSIP
N/A
CIK
1566469
Web
www.nanthealth.com
Phone
(310) 883-1300
Fax
N/A
Employees
326
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.51)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-58,260,000.00
Net Margins
-89.76%
Pretax Margin
-89.67%
Return on Equity
N/A
Return on Assets
-30.69%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.36
Quick Ratio
0.36

Sales & Book Value

Annual Sales
$62.65 million
Price / Sales
0.46
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($1.40) per share
Price / Book
-0.18

Miscellaneous

Outstanding Shares
115,550,000
Free Float
44,718,000
Market Cap
$28.89 million
Optionable
Optionable
Beta
2.00

Key Executives

  • Dr. Patrick Soon-Shiong FACSDr. Patrick Soon-Shiong FACS (Age 69)
    FRCS (C), M.Sc., Founder, Chairman & CEO
  • Mr. Bob Petrou (Age 50)
    Chief Financial Officer
    Comp: $556.27k
  • Mr. Ronald Allen LouksMr. Ronald Allen Louks (Age 57)
    Chief Operating Officer
    Comp: $837.05k
  • Mr. Mark Mozley
    Sr. VP of Corp. Devel.
  • Mr. Jerry Magin
    Sr. VP of Global Sales & Marketing
  • Mr. Arlyn R. Small Jr.
    Sr. VP of HR
  • Mr. Keith Krebs
    Sr. VP of Client Services
  • Mr. Chris House
    Sr. VP of Product Management & Devel.
  • Dr. Tiffany Avery
    Chief Medical Officer
  • Mr. Neil Carpenter
    Sr. VP of Strategy & Chief Strategy Officer

Key Competitors

View All Competitors













NH Stock - Frequently Asked Questions

Should I buy or sell NantHealth stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for NantHealth in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" NH shares.
View NH analyst ratings or view top-rated stocks.

How have NH shares performed in 2022?

NantHealth's stock was trading at $1.0550 on January 1st, 2022. Since then, NH stock has decreased by 76.3% and is now trading at $0.25.
View the best growth stocks for 2022 here.

Are investors shorting NantHealth?

NantHealth saw a increase in short interest in November. As of November 15th, there was short interest totaling 328,900 shares, an increase of 27.8% from the October 31st total of 257,400 shares. Based on an average daily trading volume, of 73,400 shares, the short-interest ratio is presently 4.5 days. Currently, 0.7% of the company's shares are short sold.
View NantHealth's Short Interest.

When is NantHealth's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our NH earnings forecast.

How were NantHealth's earnings last quarter?

NantHealth, Inc. (NASDAQ:NH) released its quarterly earnings results on Thursday, November, 3rd. The company reported ($0.13) earnings per share for the quarter. The company earned $16.63 million during the quarter.

What is Patrick Soon-Shiong's approval rating as NantHealth's CEO?

82 employees have rated NantHealth Chief Executive Officer Patrick Soon-Shiong on Glassdoor.com. Patrick Soon-Shiong has an approval rating of 49% among the company's employees. This puts Patrick Soon-Shiong in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of NantHealth own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NantHealth investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Sorrento Therapeutics (SRNE), Inovio Pharmaceuticals (INO), Micron Technology (MU), NantKwest (NK), AbbVie (ABBV), Gilead Sciences (GILD), GW Pharmaceuticals (GWPH) and Netflix (NFLX).

When did NantHealth IPO?

(NH) raised $91 million in an initial public offering on Thursday, June 2nd 2016. The company issued 6,500,000 shares at $12.50-$15.50 per share. Jefferies and Cowen and Company acted as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers.

What is NantHealth's stock symbol?

NantHealth trades on the NASDAQ under the ticker symbol "NH."

How do I buy shares of NantHealth?

Shares of NH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NantHealth's stock price today?

One share of NH stock can currently be purchased for approximately $0.25.

How much money does NantHealth make?

NantHealth (NASDAQ:NH) has a market capitalization of $28.89 million and generates $62.65 million in revenue each year. The company earns $-58,260,000.00 in net income (profit) each year or ($0.51) on an earnings per share basis.

How many employees does NantHealth have?

The company employs 326 workers across the globe.

How can I contact NantHealth?

NantHealth's mailing address is 9920 JEFFERSON BLVD, CULVER CITY CA, 90232. The official website for the company is www.nanthealth.com. The company can be reached via phone at (310) 883-1300 or via email at ir@nanthealth.com.

This page (NASDAQ:NH) was last updated on 12/5/2022 by MarketBeat.com Staff